Danaher Corporation (DHR) is “Fool’s Gold”
Danaher Corporation (NYSE: DHR) is one of them Jim Kramer discusses the US-China trade war and these 10 stocks.
Danaher Corporation (NYSE: DHR) is one of the largest manufacturers of industrial and medical research products in the United States. It is one of the most problematic stocks of the year as the stock lost 14.5% since the beginning of the year. Danaher Corporation (NYSE: DHR) stock fell 9.7% in January, down 9.7% after analysts scored their first mistake in years estimate in the fourth quarter. Analysts had been supplying pencils at $2.16 and $6.4 billion, but reported profits of $2.14 and revenues of $6.5 billion. Cramer has not been a fan of Danaher Corporation (NYSE:DHR) over the past year or so. Following quarterly revenue, he called management “Smug” and outlined his years following Danaher Corporation (NYSE: DHR). Cramer first bought the stock in 2022 and hugged them as headwinds at Danaher Corporation (NYSE: DHR) are considered to be temporary. He once again stuck to pessimism:
“My charity trust originally owned it. It was money now that was the money of a fool. I’m mad.”
Earlier this year, Cramer shared discussions with the management of Danaher Corporation (NYSE: DHR). Here’s what he said:
“I think those guys are great. The Rales brothers are great. Even if I feel bad, they still love Rales’s stakes and commanders there even more, so I love them. I just want to show me that they understand that we’re calming down.
Medical professional in a white coat holding a microscope and looking at the slide under the lens.
While we acknowledge the potential of DHR as an investment, our conviction lies in the belief that some AI stocks hold a greater promise to offer higher returns and limited downside risk. If you’re looking for a very inexpensive AI stock that is also a major beneficiary of Trump’s tariffs and supervision, check out our free report. Best Short-Term AI Stocks.
Read next: Best AI stocks to buy now and According to the billionaire, 30 best stocks to buy now.
Disclosure: None. This article was originally published Insider Monkey.